medigraphic.com
ISSN 2448-8011 (Electronic)
Revista de Divulgación del INSTITUTO DE MEDICINA FORENSE de la UNIVERSIDAD VERACRUZANA

2017, Number 2

<< Back Next >>

Rev Mex Med Forense 2017; 2 (2)

Pleomorphous adenoma of left parotid gland and lower jaw: report of a case with high risk of mortality by compression

Guillermín VC, Mendoza MRC, Melo SG, Infanzón RR

Language: Spanish
References: 31
Page: 51-61
PDF size: 731.41 Kb.


ABSTRACT

We present the case of a male patient with a pleomorphic adenoma in the left parotid and submaxillary region, with progressive growth in an individual in a homeless patient, with as high risk of morbidity and mortality due to compression of neighboring structures or malignancy. The pleomorphic adenoma is a benign neoplasm of parotid gland (85% of cases), submaxillary (7% of cases) and salivary (8% of cases); its global incidence is 1-2 per 100.000. It may appear at any age, shows a slight preference for women and is more prevalent from the fourth to the sixth decade of life; it is usually painless and slowly growing, well delimited, soft, slightly firm to palpation and freely movable in salivary glands In it doesn´t undergo surgical treatment it can reach a large volumen, usually located below the ear and behind the jaw; the older lesions can cause atrophy by compression of the bony structures and eventual malignization.


REFERENCES

  1. Regezi J, Sciubba J (2000). Patología bucal. Correlaciones clinicopatológicas. Tercera edición. Ed. McGraw-Hill Interamericana. Mexico; 243-247.

  2. Basterra A (2009). Tratado de Otorrinolaringología y Patología Cervicofacial. Ed. Elsevier Masson. Barcelona, España: 702-703, 711-714.

  3. Sapp JP, Wysocki G, Eversole LR (2004). Patología oral y maxilofacial contemporánea. 2ª ed. Ed. Elsevier. España: 347-351.

  4. Krishnaraj S (2008). Salivary gland tumors: a single institution experience in India. British Journal of Oral and Maxillofacial Surgery Association: 46: 635-638.

  5. Raspall G (2000). Boca, cabeza y cuello. Atlas clínico. Segunda edición. Ed. Masson. Barcelona – España: 2-3

  6. Pradies RG, Pérez QM, Martín AC (2008). Adenoma pleomorfo de glándulas palatinas: revisión, actualización y caso clínico. Avances en Odondotología, 15 (7): 377-84.

  7. Shaffer W, Levy B (2005). Tratado de Patología Bucal. Nueva Edit. Interamericana, México, DF: 233-238.

  8. Ledezma MC, Garcés OM, Gómez ML (2002). Adenoma pleomorfo. Asociación Dental Mexicana: 59 (2): 58-62.

  9. Waldron CA. (2001). Mixed tumor (Pleomorphic adenoma) and myoepithelioma. En: Ellis GL, Auclair PL, Gnepp DR, eds. Surgical pathology of the salivary glands. W.B. Saunders Company editores: 165-86.

  10. Raspall G. (2000). Boca, cabeza y cuello. Atlas clínico. Segunda edición. Ed. Masson. Barcelona – España: 2-3.

  11. López JP (2002). Alteraciones de las glándulas salivales. Murcia: Universidad de Murcia, Servicio de Publicaciones: 116.

  12. Sander MO (2007). Tratado de cirugía oral y maxilofacial. Introducción básica a la enseñanza. Ed. Amolca. Colombia: 665-666.

  13. D'Aversana G, Bonavolontà P, Iaconetta G (2013). Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy--our experience in 232 cases. J Oral Maxillofac Surg; 71(2):410-3.

  14. Makeieff M, Pelliccia P, Letois F (2010). Recurrent pleomorphic adenoma: results of surgical treatment. Ann Surg Oncol: 17(12): 3308-13.

  15. Witt RL, Eisele DW, Morton RP (2015). Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope: 125(4):888-93.

  16. Hadlock T, Lindsay R, Edwards C (2010). The effect of electrical and mechanical stimulation on the regenerating rodent facial nerve. Laryngoscope: 120(6):1094-102.

  17. Witt RL, Eisele DW, Morton RP. Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope: 125(4):888-93.

  18. Neville BW, Damm DD, Allen CM (2002). Oral and-Maxillofacial Pathology. 2nd ed. Philadelphia: Saunders: 426-428.

  19. Philip SJ, Eversole LR, Wysocki GP (2014). Patología Oral y maxilofacial contemporánea. 2a ed. Madrid: Elsevier, 348-351, 355-356.

  20. Conley J (1975). Recurrent pleomorphic adenoma. Salivary Glands and the Facial Nerve. New York: Grune and Stratton. 112-118.

  21. Adams AJ, Patterson AR, Brady G (2008). Resolution of obstructive sleep apnoea after resection of a pleomorphic salivary adenoma. British Journal of Oral and Maxillofacial Surgery Association; 46: 53-54.

  22. Abu-Ghanem Y, Mizrachi A, Popovtzer A (2016). Recurrent pleomorphic adenoma of the parotid gland: Institutional experience and review of the literatura. J Surg Oncol; 114(6):714-718.

  23. Gao M, Hao Y, Huang MX (2017). Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases. Int J Oral Maxillofac Surg; 46(3):343-349.

  24. Loh D, Galloway S, Slavin J (2017). Synchronous contralateral pleomorphic adenoma of the parotid gland and submandibular gland. Pathology;49(1):92-94.

  25. Neville B, Damm D, Allen C (2002). Oral & Maxilofacial Pathology. Second Edition. Philadelphia. W.B. Saunders Company:156-176.

  26. Petrovic S, Petrović D (2016). Giant pleomorphic adenoma of submandibular gland. Indian J Med Res: 144(3):485-486.

  27. Guzzo M, Locati LD, Prott FJ (2010). Major and minor salivary gland tumors. Crit Rev Oncol Hematol; 74(2):134–148.

  28. Sarmento DJ, Morais ML, Costa AL (2016). Minor intraoral salivary gland tumors: a clinical-pathological study. Einstein (Sao Paulo); 14(4):508-512.

  29. Hughes CA, Brown J (2017) .Pediatric trans-oral submandibular gland excision: A safe and effective technique. Int J Pediatr Otorhinolaryngol;93:13-16

  30. Hong HJ, Byeon HK, Bae SH (2013). Carcinoma ex pleomorphic adenoma in the oral cavity: a huge oral cavity

  31. mass with neck metástasis. J Craniofac Surg: 24(6):e543-6.




2020     |     www.medigraphic.com